Riskpilot← Back to searchSign inGet full accessNKY Sweden AB
ABBankruptOrg 5590706700All other professional, scientific and technical activities n.e.c. · NACE 7499Est. 20160 employees
Revenue 2023
SEK 1
-150% vs 2022
EBITDA margin
-309100.0%
+100% vs 2022
Equity ratio
-3668.8%
Financial strength
Net profit 2023
SEK -2,2M
+94% vs 2022
| Revenue | SEK 1 | -150% |
| EBITDA | SEK -3K | +100% |
| Net profit | SEK -2,2M | +94% |
| Total assets | SEK 120K | -95% |
| Equity | SEK -4,4M | -100% |
| Employees | 0 | — |
Legal name
NKY Sweden AB
Org number
5590706700
Legal form
Aktiebolag
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
18 juli 2016
Share capital
SEK 500 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget ska bedriva investering och förvaltning inom läkemedel, medicinsk teknik, metod, service, forskning och utveckling samt medicinska produkter eller utrustning ävensom idka förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | −0 | 0 |
| Staff expenses | — | — | — | −916 | −0 |
| EBITDA | −554 | −537 | −533 | −965 | −3 |
| Depreciation & amort. | −19 | −19 | −19 | −4 | — |
| EBIT | −573 | −556 | −552 | −969 | −3 |
| Net financials | — | — | — | −38 052 | −2 203 |
| Profit before tax | −574 | −556 | −552 | −39 021 | −2 206 |
| Tax | −0 | −0 | −0 | — | — |
| Net profit | −574 | −556 | −552 | −39 021 | −2 206 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 40 824 | 40 444 | 40 365 | 2 326 | 120 |
| Equity | 508 | 502 | 501 | −2 209 | −4 415 |
| Long-term debt | 40 253 | 39 703 | 39 802 | 1 543 | 1 543 |
| Short-term debt | 63 | 239 | 63 | 2 991 | 2 992 |
| Total debt | 40 316 | 39 942 | 39 865 | 4 534 | 4 535 |
EBITDA margin
-309100.0%
This company
15.8%
Market median
-1956429% vs market
20192023
Equity ratio
-3668.8%
This company
38.2%
Market median
-9704% vs market
20192023
Return on equity
-220643300.0%
This company
18.4%
Market median
-1199148470% vs market
20192023
Net profit margin
-220643300.0%
This company
8.1%
Market median
-2723991458% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
1.03×
This company
0.62×
Market median
-66% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NJ Liquidator | Liquidator | 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2022 – 2022 | |
JB | Board of Directors | 2022 – 2022 |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NKY Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nan Ji | Liquidator | 0 companies |
| Xiaojun Xu | Deputy Board Member | 0 companies |
| Jie Bao | Board of Directors | 0 companies |